Onconetix ONCO
NASDAQ ONCO
$0.65 -0.02 (-2.47%)
At close: Aug 21, 2026 · 4:00 PM EDT

Onconetix (ONCO) Debt Ratio (2022 - 2026)

Onconetix (ONCO) posted quarterly Debt Ratio of 0.01 for Q1 2026, down 49.36% year-over-year from 0.03 in Q1 2025, and down 93.28% quarter-over-quarter from 0.2 in Q4 2025.

Onconetix (ONCO) Debt Ratio (2022 - 2026) Analysis & Trends

Onconetix (ONCO) has reported Debt Ratio for 5 consecutive years, with 0.01 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Debt Ratio fell 49.36% year-over-year to 0.01; the TTM figure through Mar 2026 stood at 0.01 (down 49.36% YoY), while the FY2025 annual figure was 0.2, up 13.06% from the prior year.
  • Debt Ratio fell to 0.01 in Q1 2026 per ONCO's latest filing, from 0.2 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.66 in Q4 2022 and bottomed at 0.0 in Q4 2023.
  • Historically, Debt Ratio has averaged 0.11 across 5 years, with a median of 0.03 in 2025.
  • Annual changes were most pronounced in 2023 — Debt Ratio slumped 99.8% — and 2024, when it surged 12964.05%.
  • Onconetix's Debt Ratio stood at 0.66 in 2022, then plunged by 99.8% to 0.0 in 2023, then soared by 12964.05% to 0.18 in 2024, then gained by 13.06% to 0.2 in 2025, then sank by 93.28% to 0.01 in 2026.
  • Business Quant data shows ONCO's Debt Ratio at 0.01 in Q1 2026, 0.2 in Q4 2025, and 0.01 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.05
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.03
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.26
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.47
10 Onconetix 1.44 Mn -4.50 Mn 4,303.00 0.01

Historic Data

Download Data
DateValue
Jun 30, 2026 0.01
Mar 31, 2026 0.01
Dec 31, 2025 0.20
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Mar 31, 2025 0.03
Dec 31, 2024 0.18
Sep 30, 2024 0.06
Jun 30, 2024 0.02
Mar 31, 2024 0.07
Dec 31, 2023 0.00
Sep 30, 2023 0.22
Jun 30, 2023 0.02
Dec 31, 2022 0.66